The results showed that not only the number of CAR-T cells in the blood of the infused patients was expanded, but also the activity of the patient’s own CD8+T cells was enhanced, indicating that CAR-T cells infused into the human body mobilize the body’s immune cells to synergistically kill tumor cells, thereby improving antitumor efficacy [73]. Here, CD8A is linked to neoplasm.